CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

MedSym Solutions

MedSym Solutions is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sibly

Someone to talk to

Stahl James C

Stahl James C is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

A Bay Area Vital Link Inc

A Bay Area Vital Link Inc is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

National Stroke Association

National Stroke Association is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.